Addanki S.,Meas S.,Sarli V.N.,Singh B.,Lucci A. .2022 .Applications of circulating tumor cells and circulating tumor DNA in precision oncology for breast cancers. International journal of molecular sciences, 23(14) : 7843.
Arshad A.,Deutsch E.,Vozenin M.C. .2015 .Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration. PLoS One, 10(1) : e0115447.
Azevedo A.S.,Follain G.,Patthabhiraman S.,Harlepp S.,Goetz J.G. .2015 .Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?. Cell adhesion & migration, 9, (5) : 345-356.
Bodai B.I.,Tuso P. .2015 .Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. The Permanente Journal, 19(2) : 48.
Chen L.,Bode A.M.,Dong Z. .2017 .Circulating tumor cells: moving biological insights into detection. Theranostics, 7(10) : 2606.
Deng Z.,Wu S.,Wang Y.,Shi D. .2022 .Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine, 83 : .
Gold B.,Cankovic M.,Furtado L.V.,Meier F.,Gocke C.D. .2015 .Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility?: a report of the association for molecular pathology. The Journal of Molecular Diagnostics, 17(3) : 209-224.
Hanahan D. .2022 .Hallmarks of cancer: new dimensions. Cancer discovery, 12(1) : 31-46.
Hirbe A.C.,Uluçkan O.,Morgan E.A.,Eagleton M.C.,Prior J.L.,Piwnica-Worms D.,Trinkaus K.,Apicelli A.,Weilbaecher K. .2007 .Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood, 109(8) : 3424-3431.
Iliescu F.S.,Poenar D.P.,Yu F.,Ni M.,Chan K.H.,Cima I.,Cima I.,Iliescu C. .2019 .Recent advances in microfluidic methods in cancer liquid biopsy. Biomicrofluidics, 13(4) : .
Jeong Y.J.,Park S.H.,Jeon C.H.,Letters Oncology .2020 .Detection of circulating tumor cells in patients with breast cancer using the conditionally reprogrammed cell culture method and reverse transcription-PCR of hTERT and MAGE A1-6. , 20(4) : 1-1.
Liu J.,Lian J.,Chen Y.,Zhao X.,Du C.,Xu Y.,Hu H.,Rao H.,Hong X. .2021 .Circulating tumor cells (CTCs): a unique model of cancer metastases and non-invasive biomarkers of therapeutic response. Frontiers in Genetics, 12 : 734595.
Lozar T.,Gersak K.,Cemazar M.,Kuhar C.G.,Jesenko T.,Mehak T. .2019 .The biology and clinical potential of circulating tumor cells. Radiology and oncology, 53(2) : 131.
Makki J. .2015 .Diversity of breast carcinoma: histological subtypes and clinical relevance. Clinical medicine insights: Pathology, : CPath-S31563.
Markiewicz A.,Topa J.,Nagel A.,Skokowski J.,Seroczynska B.,Stokowy T.,WelnickaJaskiewicz M.,Zaczek A.J. .2019 .Spectrum of epithelial-mesenchymal transition phenotypes in circulating tumour cells from early breast cancer patients. Cancers, 11(1) : 59.
Mikulová V.,Kološtová K.,Zima T. .2011 .Methods for detection of circulating tumour cells and their clinical value in cancer patients. Folia Biol (Praha), 57(04) : 151-161.
Rack B.,Schindlbeck C.,Jückstock J.,Andergassen U.,Hepp P.,Zwingers T.,Friedl T.W.,Lorenz R.,Tesch H.,Fasching P.A.,Fehm T. .2014 .Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. Journal of the National Cancer Institute, 106(5) : dju066.
Samina J.,Khan S.A.,Talat R.,Ullah N.,Ali M.,Ayub I.,Bugti F.S.,Mustafa M.Z. .2020 .Detection of Serum Associated Proteins as Diagnostic Biomarkers in Patients suffering from Lung Cancer. National Journal of Medical and Health Sciences, 2(1) : 15-22.
Shafiq A.,Moore J.,Suleman A.,Faiz S.,Farooq O.,Arshad A.,Tehseen M.,Zafar A.,Ali S.H.,Din N.U.,Loya A. .2020 .Elevated soluble galectin-3 as a marker of chemotherapy efficacy in breast cancer patients: A prospective study. International journal of breast cancer, : .
Toss A.,Mu Z.,Fernandez S.,Cristofanilli M. .2014 .CTC enumeration and characterization: moving toward personalized medicine. Annals of translational medicine, 2(11) : 108.
Wulfing P.,Borchard J.,Buerger H.,Heidl S.,Zanker K.S.,Kiesel L.,Brandt B. .2006 .HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clinical Cancer Research, 12(6) : 1715-1720.
Yap Y.S.,Leong M.C.,Chua Y.W.,Loh K.W.J.,Lee G.E.,Lim E.H.,Dent R.,Ng R.C.H.,Lim J.H.C.,Singh G.,Tan A. .2019 .Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform. PLoS One, 14(9) : e0221305.